col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


246 Ergebisse       Seite 1

 [1] 
Wiley: Reviews in Medical Virology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jan―20 Forecasting Influenza Epidemics and Pandemics in the Age of AI and Machine Learning Oleksandr Kamyshnyi, Iryna Halabitska, Valentyn Oksenych, Iryna Kamyshna, Pavlo Petakh, Denis E. Kainov
2 [GO] 2026―Jan―03 The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review Sasidharanpillai Sabeena, Caryl Beynon
3 [GO] 2025―Dez―31 Long Covid Syndrome and Role of Autonomic Nervous System A. Vitiello
4 [GO] 2025―Dez―26 SARS-CoV-2 Genome and S2 Spike Protein: IRF-Driven Interferon Regulation and Host Cell Responses Ekta Singh, Nishita Nishi, Mudita Tripathi, Krishna Prakash
5 [GO] 2025―Dez―05 Dengue Fever: Viral, Environmental, and Human Factors Driving Expansion and Pandemic Risk Mohsen Nakhaie, Amirhossein Shahpar, Mohammad Rezaei Zadeh Rukerd, Niloofar Farsiu, Javad Charostad, Davood Bashash, et al. (+6)
6 [GO] 2025―Dez―05 COVID-19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations Rania Hamdy, Amal Z. Barakat, Eman J. Abuzaid, Tasneem M. Elsayed, Mohamed I. Husseiny
7 [GO] 2025―Nov―03 Global Hesitancy of COVID-19 Vaccine Among Vulnerable Population From 2020 to 2023: A Systematic Review and Meta-Analysis Qingsong Xu, Tianshuo Zhao, Xianming Cai, Mingting Wang, Le Ao, Tingting Wei, et al. (+10)
8 [GO] 2025―Sep―12 The Cerebral Haemorrhage and SARS-CoV-2: An Emerging Virus From a Meta-Analysis Perspective Yuxia Wang, Chao Zhang, Yunzhu Zhang, Zhuwei Zhang
9 [GO] 2025―Jul―26 The Role of Emerging/Re-Emerging RNA Viruses in Bone-Related Diseases With a Focus on DENV, CHIKV, and SARS-CoV-2 Jinxi Zhang, Jiandong Guo, Jian Li, Jiawei Gao, Jie Liu, Shuying Shen, Jianglong Zhu
10 [GO] 2025―Jul―17 An Overview of Ophthalmic Complications Associated With Emerging/Re-Emerging Viruses: Focus on ZIKV, DENV, SARS-CoV-2, and MPXV Qian Li, Wenbo Jiao, Xiaolin Li, Lingling Liang
11 [GO] 2025―Jul―15 Oral Manifestations in the Post COVID-19 Condition: A Systematic Review With Meta-Analysis Letícia Simeoni Avais, Elis Carolina Pacheco, Luisa Pereira de Oliveira Zanetti Gomes, Márcia Helena Baldani, Camila Marinelli Martins, Eliseu Alves Waldman, et al. (+3)
12 [GO] 2025―Apr―10 Emerging Viral Infections (ZIKV, SARS-CoV-2, and MPXV) and Depression: Ketamine and (S, R)-Ketamine as Promising Antidepressants Qianqian Cao, Ning Zhang, Cuibo Leng, Shoushi Wang, Jun Ma
13 [GO] 2025―Apr―08 Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection Soraya Mezouar, Jean-Louis Mege
14 [GO] 2025―Mrz―30 Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection Soraya Mezouar, Jean-Louis Mege
15 [GO] 2025―Mrz―28 Sex-Based Differences in Cardiovascular Outcomes Associated With COVID-19: A Systematic Review and Meta-Analysis Tareq M. Abubasheer, Hanan M. A. Abubasheer, Ramez M. Odat, Anas Elgenidy, Ahmed M. Afifi
16 [GO] 2025―Mrz―13 Oral SARS-CoV-2 Infection and Risk for Long Covid Joel Schwartz, Kristelle Capistrano, Heba Hussein, Avin Hafedi, Deepak Shukla, Afsar Naqvi
17 [GO] 2025―Mrz―11 Regulation of miRNA in Cytokine Storm (CS) of COVID-19 and Other Viral Infection: An Exhaustive Review Chiranjib Chakraborty, Manojit Bhattacharya, Arpita Das, Abinit Saha
18 [GO] 2025―Mrz―10 Emerging Nipah Virus With Pandemic Potential and High Mortality Rates: Is the Scientific Community Learning From Former Pandemics? Doris Klingelhöfer, Markus Braun, Christina A. Naser, Dörthe Brüggmann, David A. Groneberg
19 [GO] 2025―Mrz―10 Effect of Comorbidities on the Mortality of Patients With COVID-19: A Systematic Review of Reviews and Meta-Analyses Karla Larissa Trassi Ganaza-Domingues, Áquila Carolina Fernandes Herculano Ramos-Milaré, Daniele Stéfanie Sara Lopes Lera-Nonose, Aline Ávila Brustolin, Larissa Ferreira de Oliveira, Jonathan Sanches Rosa, et al. (+9)
20 [GO] 2024―Nov―29 Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series Omar Al-omoush, Leen Khalil, Alaa Ramadan, Husam Tarakhan, Ahmad Alzoubi, Abdallah Nabil, et al. (+3)
21 [GO] 2024―Nov―19 Neuroinflammation in Post COVID-19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk Roberta S. Dos Reis, Sathish Selvam, Velpandi Ayyavoo
22 [GO] 2024―Sep―27 The Assessment of Anti-SARS-CoV-2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta-Analysis of COVID-19 Vaccine Clinical Trial Studies Mohammad Mirzakhani, Maryam Bayat, Mohammadreza Dashti, Safa Tahmasebi, Maryam Rostamtabar, Hadi Esmaeili Gouvarchin Ghaleh, Jafar Amani
23 [GO] 2024―Sep―18 Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives Srijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, Sang-Soo Lee, Chiranjib Chakraborty
24 [GO] 2024―Aug―28 Virus-Induced Host Chemokine CCL2 in COVID-19 Pathogenesis: Potential Prognostic Marker and Target of Anti-Inflammatory Strategy Abdul Wahid Ansari, Fareed Ahmad, Majid Ali Alam, Thesni Raheed, Ahmed Zaqout, Muna Al-Maslamani, et al. (+4)
25 [GO] 2024―Aug―01 Authors' Response: Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Controlled and Randomized Clinical Trials Jayesh Beladiya, Anup Kumar, Yogesh Vasava, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, et al. (+4)
26 [GO] 2024―Jul―11 Test accuracy of rapid diagnostic tests and reverse-transcription polymerase chain reaction against virus isolation in cell culture for assessing SARS-CoV-2 infectivity: Systematic review and meta-analysis Alexey Fomenko, Theo Dähne, Stephanie Weibel, Marcus Panning, Kathrin Grummich, Sabrina Schlesinger, et al. (+2)
27 [GO] 2024―Jun―28 Follicular oocyte as a potential target for severe acute respiratory syndrome coronavirus 2 infection Pramod K. Yadav, Ashutosh N. Pandey, Karuppanan V. Premkumar, Meenakshi Tiwari, Ajai K. Pandey, Shail K. Chaube
28 [GO] 2024―Jun―26 Exosomes, and the potential for exosome-based interventions against COVID-19 Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, Kimia Behzad Moghadam, Zahra Vaziri, Ali Hosein Tabar Kashi, et al. (+7)
29 [GO] 2024―Jun―08 Azvudine versus Paxlovid in COVID-19: A systematic review and meta-analysis Behnam Amani, Bahman Amani
30 [GO] 2024―Jun―03 Fluvoxamine and long COVID: Post-acute recovery Angela M. Reiersen, Charles F. Zorumski, Eric J. Lenze
31 [GO] 2024―Mai―24 SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19 Joel Schwartz, Kristelle J. Capistrano, Joseph Gluck, Armita Hezarkhani, Afsar R. Naqvi
32 [GO] 2024―Apr―18 Passive immunotherapies for the next influenza pandemic Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew Pekosz, et al. (+2)
33 [GO] 2024―Mrz―21 Risk of kidney and liver diseases after COVID-19 infection: A systematic review and meta-analysis Bei Pan, Xiaoman Wang, Honghao Lai, Robin W. M. Vernooij, Xiyuan Deng, Ning Ma, et al. (+8)
34 [GO] 2024―Mrz―06 Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS-CoV-2 and other respiratory viruses: A comprehensive review Chiranjib Chakraborty, Manojit Bhattacharya, Sang-Soo Lee
35 [GO] 2024―Feb―03 Duration of protective immunity following COVID-19 vaccination of individuals with underlying health conditions: A rapid review Kieran A. Walsh, Helen O’Donnell, Mark O’Loughlin, Heather Eames, Jingjing Jiang, Katie M. O’Brien, et al. (+14)
36 [GO] 2024―Feb―01 Increased risk of new-onset cardiovascular disease after COVID-19: A systematic review and meta-analysis of 14 cohorts Mingyao Sun, Mengyuan Yuan, Honghao Lai, Qian Wang, Hengyang Wang, Lina Xing, et al. (+3)
37 [GO] 2024―Jan―24 Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, Sai Nikhila Ghanta, Anusha Bommasani, Anitha Kuttiappan, et al. (+10)
38 [GO] 2024―Jan―09 An overview of SARS-CoV2 natural infections in companion animals: A systematic review of the current evidence Zahra Heydarifard, Ardalan Maleki Chegeni, Fatemeh Heydarifard, Bahram Nikmanesh, Vahid Salimi
39 [GO] 2024―Jan―09 The controversy of SARS-CoV-2 integration into the human genome Laith AL-Eitan, Ahmad Mihyar
40 [GO] 2024―Jan―05 Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID-19 infection Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, Yeganeh Farnamian, Roya Naderi, Ladan Jalali
41 [GO] 2024―Jan―04 Prevalence and outcomes of upper gastrointestinal bleeding in COVID-19: A systematic review and meta-analysis Sawai Singh Rathore, Zario Shai Wint, Aman Goyal, Bijay Mukesh Jeswani, Ameer Mustafa Farrukh, María Alejandra Nieto-Salazar, et al. (+7)
42 [GO] 2023―Dez―30 Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials Jayesh Beladiya, Anup Kumar, Yogesh Vasava, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, et al. (+4)
43 [GO] 2023―Dez―29 Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid-19 Han Wang, Li Cheng, Lanlan Yu, Zhigang Guo
44 [GO] 2023―Dez―27 Evaluating fluvoxamine for the outpatient treatment of COVID-19: A systematic review and meta-analysis Jiawen Deng, Myron Moskalyk, Qi Kang Zuo, Cristian Garcia, Umaima Abbas, Harikrishnaa Ba Ramaraju, et al. (+5)
45 [GO] 2023―Dez―21 Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID-19 Aroona Razzaq, Cyrollah Disoma, Yuzheng Zhou, Siyi Tao, Zongpeng Chen, Sixu Liu, et al. (+10)
46 [GO] 2023―Nov―29 Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis Yue Wang, Dong Chen, Yuancan Pan, Haiming Li, Weizhe Zhao, Taicheng Lu, et al. (+4)
47 [GO] 2023―Nov―23 Comparable performance of antigen-detecting rapid test by healthcare worker-collected and self-collected swabs for SARS-CoV-2 diagnostic: A systematic review and meta-analysis Samuel Johnson Kurniawan, Maria Mardalena Martini Kaisar, Helen Kristin, Soegianto Ali
48 [GO] 2023―Nov―17 Reply to Kleebayoon and Wiwanitkit on ‘Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis’ Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Laurie Butler, Ai Koyanagi, Louis Jacob, et al. (+2)
49 [GO] 2023―Okt―05 COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes Bruno Azevedo Randi, Hermes Ryoiti Higashino, Vinícius Ponzio da Silva, Erick Menezes Xavier, Vanderson Rocha, Silvia Figueiredo Costa
50 [GO] 2023―Sep―28 Modulation of various host cellular machinery during COVID-19 infection Shivani Malvankar, Anjali Singh, Y. S. Ravi Kumar, Swetangini Sahu, Megha Shah, Yamini Murghai, et al. (+3)
51 [GO] 2023―Sep―14 Lactate dehydrogenase contribution to symptom persistence in long COVID: A pooled analysis Raphael Udeh, Alberto Utrero-Rico, Xenia Dolja-Gore, Masoud Rahmati, Mark McEVoy, Tony Kenna
52 [GO] 2023―Aug―14 Appraisal of evidence reliability and applicability of Paxlovid as treatment for SARS-COV-2 infection: A systematic review Chang-tai Zhu, Jian-Yun Yin, Xiao-hua Chen, Ming Liu, Shi-gui Yang
53 [GO] 2023―Aug―02 SARS-CoV-2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs N. Aravind Kumar, S. Aradhana, M. R. Vishnuraj
54 [GO] 2023―Jul―24 Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID-19: An updated meta-analysis and trial sequential analysis Haokun Tian, Changsen Yang, Tiangang Song, Kechen Zhou, Lequan Wen, Ye Tian, et al. (+3)
55 [GO] 2023―Jun―25 Strongyloides coinfection in COVID-19 patients treated with corticosteroids: A systematic review Sana Zulfiqar, Robin B. Gasser, Sahar Ghodsian, Mustafa Almukhtar, Celia Holland, Ali Rostami
56 [GO] 2023―Jun―21 Transmission of mpox in educational settings and risk of severe disease in children and adolescents-Let's not make the same mistakes as COVID-19 again Konstantinos Karampatsas, Asma Khalil, Paul T. Heath, Kirsty Le Doare, Shamez N. Ladhani
57 [GO] 2023―Jun―16 SARS-CoV-2 neutralising antibody therapies: Recent advances and future challenges Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, Li Liu, Qiwen Liu, Yiyin Mai, et al. (+6)
58 [GO] 2023―Jun―12 Host genetic determinants of COVID-19 susceptibility and severity: A systematic review and meta-analysis Setegn Eshetie, Pastor Jullian, Beben Benyamin, S. Hong Lee
59 [GO] 2023―Mai―05 Differentially-regulated miRNAs in COVID-19: A systematic review Waqar Ahmad, Bushra Gull, Jasmin Baby, Neena G. Panicker, Thanumol A. Khader, Shaima Akhlaq, et al. (+2)
60 [GO] 2023―Apr―19 Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis Negin Farhadian, Sara Sharifi, Mahdi Taghadosi, Maryam Farhadian, Siavash Vaziri
61 [GO] 2023―Apr―17 Sex affects immune response capacity against COVID-19 infection Andrea Zovi, Francesco Ferrara, Roberto Langella, Fabiola Cavallaro, Antonio Vitiello
62 [GO] 2023―Apr―14 Comment on COVID-19 vaccination during pregnancy, COVID and maternal and neonatal outcomes Amnuay Kleebayoon, Viroj Wiwanitkit
63 [GO] 2023―Apr―08 Interleukin-6 inhibitory effect of natural product naringenin compared to a synthesised monoclonal antibody against life-threatening COVID-19 Melika AmeliMojarad, Mandana AmeliMojarad
64 [GO] 2023―Apr―06 Implications of potential clinically relevant interactions between COVID-19 vaccines and concomitant medications Osama A. Badary
65 [GO] 2023―Mrz―21 Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis Alireza Mohebbi, Habib Haybar, Fatemeh Nakhaei Moghaddam, Zahra Rasti, Mohammad Amin Vahid, Najmaldin Saki
66 [GO] 2023―Mrz―14 The role of corticosteroids may be different in patients with COVID-19 Xiaolu Shao, Qianghong Xu
67 [GO] 2023―Mrz―11 Efficacy of therapeutic plasma exchange in patients with severe COVID-19: A systematic review and meta-analysis Omar Ahmed Abdelwahab, Rehab Adel Diab, Khaled Saad Elsaeidy, Khaled Albakri, Mohamed El-Samahy, Omar Ramadan, et al. (+3)
68 [GO] 2023―Mrz―10 Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Laurie Butler, Ai Koyanagi, Louis Jacob, et al. (+2)
69 [GO] 2023―Mrz―07 Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis Arman Shafiee, Mohammad Mobin Teymouri Athar, Mohammad Javad Amini, Hamed Hajishah, Sepehr Siahvoshi, Mehrsa Jalali, et al. (+2)
70 [GO] 2023―Feb―18 Prevalence and clinical outcomes of COVID-19 in patients with pre-existing celiac disease: A systematic review and meta-analysis Sawai Singh Rathore, Felipe Velasquez-Botero, María Alejandra Nieto-Salazar, Thomas C. Flowers, Jamal Hasan, Ashwani Kumar Parashar, et al. (+7)
71 [GO] 2023―Feb―18 Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: Systematic review and meta-analysis Márcio Antonio Ferreira Arantes Junior, Ana Flávia Conegundes, Bárbara Castello Branco Miranda, Alexia Stenner Rodrigues Radicchi Campos, Ana Luiza França Vieira, Matheus Daniel Faleiro, et al. (+3)
72 [GO] 2023―Feb―15 Clinical performance of rapid antigen tests in comparison to RT-PCR for SARS-COV-2 diagnosis in Omicron variant: A systematic review and meta-analysis Zahra Eslami Mohammadie, Saeed Akhlaghi, Saeed Samaeinasab, Shakiba Shaterzadeh-Bojd, Tannaz Jamialahmadi, Amirhossein Sahebkar
73 [GO] 2023―Feb―15 SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Fazel Shokri
74 [GO] 2023―Feb―15 Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system Philipp Niklas Ostermann, Heiner Schaal
75 [GO] 2023―Feb―13 Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, Abia Shahid, Muhammad Shahzil, Mohammad Ebad Ur Rehman, et al. (+3)
76 [GO] 2023―Feb―02 The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
77 [GO] 2023―Jan―09 Efficacy and safety of tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: A systematic review and meta-analysis Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, Timotius Ivan Hariyanto
78 [GO] 2023―Jan―05 Anakinra was not associated with lower mortality in hospitalised COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials Wenli Shang, Yingying Zhang, Guizuo Wang, Dong Han
79 [GO] 2022―Dez―12 COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis Min Ho Lee, Han Jacob Li, Paul Wasuwanich, Sung Eun Kim, Jong Yeob Kim, Gwang Hun Jeong, et al. (+11)
80 [GO] 2022―Dez―06 Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis Mahdi Taghadosi, Elham Safarzadeh, Ali Asgarzadeh, Seyed Askar Roghani, Afsaneh Shamsi, Cyrus Jalili, et al. (+9)
81 [GO] 2022―Dez―01 B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone? Sourabh Soni, Yohannes A. Mebratu
82 [GO] 2022―Nov―24 Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review Han Li, Chelsea-Jane Arcalas, Junmin Song, Masoud Rahmati, Seoyeon Park, Ai Koyanagi, et al. (+4)
83 [GO] 2022―Nov―08 Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, Samah A. Loutfy, Sara Sami ElKaffas, Nasra F. Abdel Fattah, Mohamed Hessien
84 [GO] 2022―Okt―13 Efficacy and safety of sotrovimab in patients with COVID-19: A rapid review and meta-analysis Bahman Amani, Behnam Amani
85 [GO] 2022―Sep―23 SARS-CoV-2 Omicron and its current known unknowns: A narrative review Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Hau Nguyen Thi Hien, I-Chun Hung, Mai Ngoc Luu, Zeeshan Ali Khan, et al. (+7)
86 [GO] 2022―Sep―13 Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis Robert Marcec, Vinko Michael Dodig, Igor Radanovic, Robert Likic
87 [GO] 2022―Sep―03 Testosterone and Covid-19: An update Aksam Yassin, Ridwan Sabsigh, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Mustafa Alwani, Joanne Nettleship, Daniel Kelly
88 [GO] 2022―Aug―27 Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: A meta-analysis Sawai Singh Rathore, Sharvi Oberoi, Kinza Iqbal, Keshav Bhattar, Guadalupe Abigail Benítez-López, María Alejandra Nieto-Salazar, et al. (+7)
89 [GO] 2022―Aug―27 Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review Mohammad Mahdi Rezaei Tolzali, Maryam Noori, Pourya Shokri, Shayan Rahmani, Shokoufeh Khanzadeh, Seyed Aria Nejadghaderi, et al. (+6)
90 [GO] 2022―Aug―27 Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2? Emad Behboudi, Hossein Teimouri
91 [GO] 2022―Aug―27 Response to the letter, entitled ‘Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2?’ Rania Hamdy, Sameh S. M. Soliman
92 [GO] 2022―Aug―16 Effect of corticosteroid therapy on mortality in COVID-19 patients-A systematic review and meta-analysis Chirag Patel, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Devang Sheth, Jayesh V. Beladiya
93 [GO] 2022―Jul―20 Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission Lok Bahadur Shrestha, Charles Foster, William Rawlinson, Nicodemus Tedla, Rowena A. Bull
94 [GO] 2022―Jul―12 The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis Zorana Dobrijević, Nikola Gligorijević, Miloš Šunderić, Ana Penezić, Goran Miljuš, Sergej Tomić, Olgica Nedić
95 [GO] 2022―Jun―10 Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis Hanna Krumbein, Lara S. Kümmel, Paraskevi C. Fragkou, Clemens Thölken, Ben L. Hünerbein, Rieke Reiter, et al. (+3)
96 [GO] 2022―Jun―04 Recent insights into SARS-CoV-2 omicron variant Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, Keith Pardee
97 [GO] 2022―Mai―27 The role of cytokines and their antagonists in the treatment of COVID-19 patients Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, et al. (+6)
98 [GO] 2022―Mai―18 Potential intestinal infection and faecal-oral transmission of human coronaviruses Tingting Ning, Si Liu, Junxuan Xu, Yi Yang, Nan Zhang, Sian Xie, et al. (+4)
99 [GO] 2022―Mai―02 Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, Seyed Aria Nejadghaderi, Masoomeh Masoomikarimi, Masoumeh Alimohammadi, Nima Rezaei
100 [GO] 2022―Apr―28 Biomarker based biosensors: An opportunity for diagnosis of COVID-19 Reza Khaksarinejad, Zohreh Arabpour, Leila RezaKhani, Farzad Parvizpour, Yousef Rasmi
101 [GO] 2022―Apr―21 Omicron - The new SARS-CoV-2 challenge? A. Lino, M. A. Cardoso, P. Martins-Lopes, H. M. R. Gonçalves
102 [GO] 2022―Apr―13 Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines Narasimha M. Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan
103 [GO] 2022―Apr―13 Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis Masoud Rahmati, Mahdieh Molanouri Shamsi, Kayvan Khoramipour, Fatemeh Malakoutinia, Wongi Woo, Seoyeon Park, et al. (+4)
104 [GO] 2022―Apr―13 Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis Samuel J. Minkove, Junfeng Sun, Yan Li, Xizhong Cui, Diane Cooper, Peter Q. Eichacker, Parizad Torabi-Parizi
105 [GO] 2022―Apr―13 Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach Camilla Costa Silva, Clea Nazaré Carneiro Bichara, Francisca Regina Oliveira Carneiro, Vera Regina da Cunha Menezes Palacios, Ana Virgínia Soares Van den Berg, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
106 [GO] 2022―Apr―05 Reflections after 2 years of COVID-19 pandemic Daniele Focosi, Arturo Casadevall, Fabrizio Maggi, Guido Antonelli
107 [GO] 2022―Apr―02 Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse-transcription polymerase chain reaction: A systematic review and meta-analysis Alexey Fomenko, Stephanie Weibel, Helia Moezi, Kristina Menger, Christine Schmucker, Maria-Inti Metzendorf, et al. (+6)
108 [GO] 2022―Mrz―31 Antioxidant/anti-inflammatory effect of Mg 2+ in coronavirus disease 2019 (COVID-19) Yalith Lyzet Arancibia-Hernández, Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, José Pedraza-Chaverri
109 [GO] 2022―Mrz―29 Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review Kieran A. Walsh, Natasha Broderick, Susan Ahern, Christopher G. Fawsitt, Katie M. O’Brien, Marie Carrigan, et al. (+6)
110 [GO] 2022―Mrz―11 Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible Daniele Focosi, Massimo Franchini
111 [GO] 2022―Mrz―10 Prevalence of oral manifestations in COVID-19: A systematic review Preeti Sharma, Sangeeta Malik, Vijay Wadhwan, Suhasini Gotur Palakshappa, Roli Singh
112 [GO] 2022―Mrz―05 COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients Amr Ehab El-Qushayri, Amira Yasmine Benmelouka, Abdullah Dahy, Mohammad Rashidul Hashan
113 [GO] 2022―Mrz―03 SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management Chowdhury Nusaiba Binte Sayed Prapty, Raad Rahmat, Yusha Araf, Samiha Kamal Shounak, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen, et al. (+2)
114 [GO] 2022―Feb―25 Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence Amr Ehab El-Qushayri, Ahmed Mostafa Ahmed Kamel, Abdullah Reda, Sherief Ghozy
115 [GO] 2022―Feb―09 Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian
116 [GO] 2022―Feb―03 SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Seyed Rouhollah Miri, et al. (+5)
117 [GO] 2022―Jan―08 Genetic polymorphisms of ACE1 , ACE2 , and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis Wacharapol Saengsiwaritt, Jiraphun Jittikoon, Usa Chaikledkaew, Wanvisa Udomsinprasert
118 [GO] 2022―Jan―06 Great expectations: Living with and not dying from Covid-19 Philip P. Mortimer
119 [GO] 2021―Dez―27 Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review Saba Zanganeh, Nima Goodarzi, Mohammad Doroudian, Elaheh Movahed
120 [GO] 2021―Dez―18 Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series Asra Fazlollahi, Mahdi Zahmatyar, Maryam Noori, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Reza Shekarriz-Foumani, et al. (+3)
121 [GO] 2021―Dez―10 Caution should be exercised when assessing ivermectin for the treatment of COVID-19 in systematic reviews Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Kyra Kavanagh
122 [GO] 2021―Dez―07 Complement inhibition: A possible therapeutic approach in the fight against Covid-19 Niloofar Deravi, Elahe Ahsan, Mobina Fathi, Parastoo Hosseini, Shirin Yaghoobpoor, Ramin Lotfi, et al. (+2)
123 [GO] 2021―Dez―03 Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics? Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Fabrizio Maggi, Arturo Casadevall
124 [GO] 2021―Nov―10 Covid-19 vaccines and variants of concern: A review Ikbel Hadj Hassine
125 [GO] 2021―Nov―02 Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals Rebecca L. Pedler, Peter G. Speck
126 [GO] 2021―Okt―30 Role of ORF8a as accessory protein in apoptosis induction in SARS-CoV-2 infection Milad Zandi, Hassan Karami
127 [GO] 2021―Okt―29 A comparison with historical influenza prompts better planning for Covid-19 and future pandemics, and gives grounds for optimism Philip Mortimer
128 [GO] 2021―Okt―26 Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ali Teimoori, Ebrahim Azimi, et al. (+7)
129 [GO] 2021―Okt―22 Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Feizollah Mansouri, Terence T. Sio, Mark J. M. Sullman, et al. (+4)
130 [GO] 2021―Okt―21 Hospitalised versus outpatient COVID-19 patients' background characteristics and comorbidities: A systematic review and meta-analysis Paola P. Mattey-Mora, Connor A. Begle, Candice K. Owusu, Chen Chen, Maria A. Parker
131 [GO] 2021―Okt―16 The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis Harapan Harapan, Jonny Karunia Fajar, Supriono Supriono, Gatot Soegiarto, Laksmi Wulandari, Fiha Seratin, et al. (+25)
132 [GO] 2021―Okt―08 Protection offered by SARS coronavirus 2 vaccines against disease and infection Paul D. Griffiths
133 [GO] 2021―Okt―01 Behaviour of aerosols and their role in the transmission of SARS-CoV-2; a scoping review José Miguel Robles-Romero, Gloria Conde-Guillén, Juan Carlos Safont-Montes, Francisca María García-Padilla, Macarena Romero-Martín
134 [GO] 2021―Sep―30 Cell death mechanisms involved in cell injury caused by SARS-CoV-2 Maríllya Morais da Silva, André Silva Lira de Lucena, Sergio de Sá Leitão Paiva Júnior, Vanessa Mylenna Florêncio De Carvalho, Priscilla Stela Santana de Oliveira, Michelle Melgarejo Rosa, et al. (+3)
135 [GO] 2021―Sep―28 Pharmacological interventions to prevent Covid-19 disease: A rapid review Karen Cardwell, Eamon O Murchu, Paula Byrne, Natasha Broderick, Kieran A. Walsh, Sinéad M. O'Neill, et al. (+4)
136 [GO] 2021―Sep―24 Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis Jingwen Peng, Meihua Fu, Huan Mei, Hailin Zheng, Guanzhao Liang, Xiaodong She, et al. (+2)
137 [GO] 2021―Sep―21 The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression Zheng Yao Low, Ashley Jia Wen Yip, Vincent T. K. Chow, Sunil K. Lal
138 [GO] 2021―Sep―17 Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection Daniela Mateus, Ana Isabel Sebastião, Mylène A. Carrascal, Anália do Carmo, Ana Miguel Matos, Maria Teresa Cruz
139 [GO] 2021―Sep―13 Ethnicity as a risk factor for vitamin D deficiency and undesirable COVID-19 outcomes Amir Reza Akbari, Maaz Khan, William Adeboye, Lawrence Hin Hai Lee, Sabbir Islam Chowdhury
140 [GO] 2021―Sep―13 Laboratory biomarkers and prognosis in Covid-19, where do we stand? Alisha Israni, Christopher J. Goulden, Amer Harky
141 [GO] 2021―Sep―09 Long-term side effects and lingering symptoms post COVID-19 recovery Mohammad Zarei, Deepanwita Bose, Masoud Nouri-Vaskeh, Vida Tajiknia, Ramin Zand, Mehdi Ghasemi
142 [GO] 2021―Sep―08 Severe acute respiratory syndrome-2 encodes hemagglutinin esterase? Milad Zandi
143 [GO] 2021―Sep―02 Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis Le Huu Nhat Minh, Ali Ahmed-Fouad Abozaid, Nam Xuan Ha, Loc Le Quang, Abdelrahman Gamil Gad, Ranjit Tiwari, et al. (+10)
144 [GO] 2021―Aug―14 Effectiveness of public health measures to prevent the transmission of SARS-CoV-2 at mass gatherings: A rapid review Kieran A. Walsh, Barrie Tyner, Natasha Broderick, Patricia Harrington, Michelle O’Neill, Christopher G. Fawsitt, et al. (+4)
145 [GO] 2021―Aug―07 Mesenchymal stem cells and their derived exosomes to combat Covid-19 Maryam Yousefi Dehbidi, Nima Goodarzi, Mohammad H. Azhdari, Mohammad Doroudian
146 [GO] 2021―Aug―02 Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020? João Locke Araújo, Diego Menezes, Julia Maria Saraiva-Duarte, Luciana Ferreira, Renato Aguiar, Renan Souza
147 [GO] 2021―Aug―02 An overview on the seven pathogenic human coronaviruses Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, Milad Zandi
148 [GO] 2021―Jul―31 Authors’ response: Ethnicity and vitamin D supplementations for COVID-19 Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan
149 [GO] 2021―Jul―19 Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, Kristin Carson-Chahhoud, Khalil Ansarin, Ali-Asghar Kolahi, Saeid Safiri
150 [GO] 2021―Jul―14 The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis Amr Ehab El-Qushayri, Sherief Ghozy, Abdullah Reda, Ahmed Mostafa Ahmed Kamel, Alzhraa Salah Abbas, Adam A. Dmytriw
151 [GO] 2021―Jul―10 Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis Tejpal Gupta, Prafulla Thakkar, Babusha Kalra, Sadhana Kannan
152 [GO] 2021―Jul―06 Rational procedures for this and the next virus pandemic Philip P Mortimer
153 [GO] 2021―Jul―03 Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments Biswajit Maiti, Karanth Padyana Anupama, Praveen Rai, Indrani Karunasagar, Iddya Karunasagar
154 [GO] 2021―Jul―02 Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Mandana Afsharian, Kiarash Saleki, Mohammad Barary, Soheil Ebrahimpour
155 [GO] 2021―Jul―01 Persistence of humoral response upon SARS-CoV-2 infection Andrea Knies, Dennis Ladage, Ralf J. Braun, Janine Kimpel, Miriam Schneider
156 [GO] 2021―Jun―27 Vitamin D supplementation and Covid-19 outcomes: A systematic review, meta-analysis and meta-regression Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan
157 [GO] 2021―Jun―27 Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S-glycoprotein, infectivity, re-infectivity, immune escape and vaccines activity Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma
158 [GO] 2021―Jun―24 Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19 Ranjita Misra, Sarbari Acharya, Nehru Sushmitha
159 [GO] 2021―Jun―07 Ivermectin and outcomes from Covid-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies Timotius Ivan Hariyanto, Devina Adella Halim, Jane Rosalind, Catherine Gunawan, Andree Kurniawan
160 [GO] 2021―Jun―07 Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis Soumya Sarkar, Sundara Kannan, Puneet Khanna, Akhil Kant Singh
161 [GO] 2021―Jun―03 Epidemiology, prognosis and management of potassium disorders in Covid-19 Maryam Noori, Seyed A. Nejadghaderi, Mark J. M. Sullman, Kristin Carson-Chahhoud, Ali-Asghar Kolahi, Saeid Safiri
162 [GO] 2021―Jun―03 Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials Ahmed M. Kamel, Mona S. A. Monem, Nour A. Sharaf, Nada Magdy, Samar F. Farid
163 [GO] 2021―Mai―27 Quantifying the risk of SARS-CoV-2 reinfection over time Eamon O Murchu, Paula Byrne, Paul G. Carty, Cillian De Gascun, Mary Keogan, Michelle O’Neill, et al. (+2)
164 [GO] 2021―Mai―24 Oral manifestations of Covid-19-A literature review Huma Farid, Madiha Khah, Shizrah Jamal, Robia Ghafoor
165 [GO] 2021―Mai―14 The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review Pourya Shokri, Saeid Golmohammadi, Maryam Noori, Seyed Aria Nejadghaderi, Kristin Carson-Chahhoud, Saeid Safiri
166 [GO] 2021―Mai―14 A rapid review of measures to support people in isolation or quarantine during the Covid-19 pandemic and the effectiveness of such measures Karen Cardwell, Sinéad M. O’Neill, Barrie Tyner, Natasha Broderick, Kirsty O’Brien, Susan M. Smith, et al. (+3)
167 [GO] 2021―Apr―22 Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials Timothée Klopfenstein, Vincent Gendrin, N'dri Juliette Kadiane-Oussou, Thierry Conrozier, Souheil Zayet
168 [GO] 2021―Apr―01 Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far? Abdellatif Bouayad
169 [GO] 2021―Mrz―25 Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models Ece Egilmezer, William D Rawlinson
170 [GO] 2021―Mrz―16 Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines Daniele Focosi, Fabrizio Maggi
171 [GO] 2021―Mrz―16 Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus Farzaneh Darbeheshti, Mojdeh Mahdiannasser, Bruce D Uhal, Shuji Ogino, Sudhir Gupta, Nima Rezaei
172 [GO] 2021―Mrz―13 Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France Chloé Dimeglio, Marcel Miedougé, Jean-Michel Loubes, Jean-Michel Mansuy, Jacques Izopet
173 [GO] 2021―Mrz―05 Vaccines for SARS coronavirus 2 and the new normal in vaccinology P. D. Griffiths
174 [GO] 2021―Mrz―01 Sex-based differences in severity and mortality in COVID-19 Mustafa Alwani, Aksam Yassin, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Joanne Nettleship, Daniel Kelly, et al. (+2)
175 [GO] 2021―Mrz―01 Covid-19 and oral diseases: Crosstalk, synergy or association? Daniela A. Brandini, Aline S. Takamiya, Pari Thakkar, Samantha Schaller, Rani Rahat, Afsar R. Naqvi
176 [GO] 2021―Feb―23 Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics Jenifer Kiem Aviani, Danny Halim, Arto Yuwono Soeroto, Tri Hanggono Achmad, Tono Djuwantono
177 [GO] 2021―Feb―20 C-reactive protein as an effector molecule in Covid-19 pathogenesis Jesús A. Mosquera-Sulbaran, Adriana Pedreañez, Yenddy Carrero, Diana Callejas
178 [GO] 2021―Feb―17 SARS-CoV-2, Covid-19, and the debunking of conspiracy theories Mohamad S. Hakim
179 [GO] 2021―Jan―21 Loop-mediated isothermal amplification (LAMP): An effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2 Melek Chaouch
180 [GO] 2021―Jan―20 Coronavirus disease 2019 as a syndemic Griffiths Paul
181 [GO] 2021―Jan―15 Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients Mohammad Mahmudur Rahman, Maruf Hasan, Asif Ahmed
182 [GO] 2021―Jan―15 Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19 Jiezhong Chen, Sean Hall, Luis Vitetta
183 [GO] 2021―Jan―15 Lipid-based therapies against SARS-CoV-2 infection Eman Humaid Alketbi, Rania Hamdy, Abdalla El-Kabalawy, Viktorija Juric, Marc Pignitter, Kareem Mosa, et al. (+3)
184 [GO] 2021―Jan―02 Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis Maryamsadat Jafari, Ali Pormohammad, Saeideh Aghayari Sheikh Neshin, Saied Ghorbani, Deepanwita Bose, Shohreh Alimohammadi, et al. (+6)
185 [GO] 2021―Jan―02 How strong is the evidence that it is possible to get SARS-CoV-2 twice? A systematic review Larabe Farrukh, Aqsa Mumtaz, Muhammad K. Sana
186 [GO] 2020―Dez―31 Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings Ish K. Midha, Nilesh Kumar, Amit Kumar, Taruna Madan
187 [GO] 2020―Dez―26 Classical and alternative receptors for SARS-CoV-2 therapeutic strategy Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub
188 [GO] 2020―Dez―25 Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm Ian A. Clark
189 [GO] 2020―Dez―19 How artificial intelligence may help the Covid-19 pandemic: Pitfalls and lessons for the future Yashpal Singh Malik, Shubhankar Sircar, Sudipta Bhat, Mohd Ikram Ansari, Tripti Pande, Prashant Kumar, et al. (+7)
190 [GO] 2020―Dez―05 Population-based prevalence surveys during the Covid-19 pandemic: A systematic review Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, Janini Cristina Paiz, Gabriel Dickin Caldana, Carem Luana Machado Lessa, et al. (+7)
191 [GO] 2020―Dez―05 Immunity and inflammatory biomarkers in COVID-19: A systematic review Ana Paula D. Iwamura, Marielen R. Tavares da Silva, Ana Luísa Hümmelgen, Paulo V. Soeiro Pereira, Angela Falcai, Anete Sevciovic Grumach, et al. (+3)
192 [GO] 2020―Nov―21 A systematic meta-analysis of immune signatures in patients with COVID-19 Kun Liu, Tong Yang, Xue-Fang Peng, Shou-Ming Lv, Xiao-lei Ye, Tian-Shuo Zhao, et al. (+5)
193 [GO] 2020―Nov―18 Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review Salma Younes, Nadin Younes, Farah Shurrab, Gheyath K. Nasrallah
194 [GO] 2020―Nov―18 Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment Laith N. AL-Eitan, Saif Z. Alahmad
195 [GO] 2020―Nov―11 Impact of COVID-19 on polio vaccination in Pakistan: a concise overview Misbahud Din, Hammad Ali, Mudassir Khan, Abdul Waris, Sana Ullah, Muhammad Kashif, et al. (+2)
196 [GO] 2020―Nov―07 The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence Karen Cardwell, Karen Jordan, Paula Byrne, Susan M. Smith, Patricia Harrington, Mairin Ryan, Michelle O'Neill
197 [GO] 2020―Nov―05 Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta-analysis Daniel Mekonnen, Hylemariam Mihiretie Mengist, Awoke Derbie, Endalkachew Nibret, Abaineh Munshea, Hongliang He, et al. (+2)
198 [GO] 2020―Okt―31 Intricate interplay between Covid-19 and cardiovascular diseases Vishakh C. Keri, Amit Hooda, Parul Kodan, Brunda R L, Pankaj Jorwal, Naveet Wig
199 [GO] 2020―Okt―31 Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis Hozaifa Khalil Elsawah, Mohamed Ahmed Elsokary, Mahmoud Samy Abdallah, Ahmed Hanei ElShafie
200 [GO] 2020―Okt―26 YouTube as a source of patient information for Covid-19: An enhanced content-quality and audience engagement analysis Wajahat Mughal, Zahid Mohammed, Abdullah Zafar, Benyamin Alam
201 [GO] 2020―Okt―26 Airborne transmission of SARS-CoV-2 via aerosols Laura Comber, Eamon O Murchu, Linda Drummond, Paul G. Carty, Kieran A. Walsh, Cillian F. De Gascun, et al. (+5)
202 [GO] 2020―Okt―22 Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review Laura Comber, Kieran A. Walsh, Karen Jordan, Kirsty K. O'Brien, Barbara Clyne, Conor Teljeur, et al. (+7)
203 [GO] 2020―Okt―15 Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, et al. (+6)
204 [GO] 2020―Okt―09 Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings Ali Pormohammad, Saied Ghorbani, Alireza Khatami, Mohammad Hossein Razizadeh, Ehsan Alborzi, Mohammad Zarei, et al. (+2)
205 [GO] 2020―Okt―06 Covid-19 and kidney injury: Pathophysiology and molecular mechanisms Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Saiedeh Razi Soofiyani, Sima Abediazar, Mohammadali M. Shoja, Mohammadreza Ardalan, Sepideh Zununi Vahed
206 [GO] 2020―Okt―06 Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies Ahmed M. Kamel, Mona Sobhy, Nada Magdy, Nirmeen Sabry, Samar Farid
207 [GO] 2020―Okt―06 Clotting disorder in severe acute respiratory syndrome coronavirus 2 Sujit Pujhari, Sanjeeta Paul, Jasmina Ahluwalia, Jason L. Rasgon
208 [GO] 2020―Okt―01 Is there light at the end of the Covid-19 tunnel? Philip P. Mortimer
209 [GO] 2020―Sep―25 The complexity of respiratory disease associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: From immunopathogenesis to respiratory therapy Luiz Fábio Falcão, Lucieny da Silva Pontes, Bruno Giovanni Afonso da Silva, Karen Margarete Vieira da Silva Franco, Luiz Adriano Costa, Rodrigo Santiago Barbosa Rocha, Juarez Antônio Simões Quaresma
210 [GO] 2020―Sep―23 Immune response following infection with SARS-CoV -2 and other coronaviruses: A rapid review Eamon O Murchu, Paula Byrne, Kieran A. Walsh, Paul G. Carty, Máire Connolly, Cillian De Gascun, et al. (+8)
211 [GO] 2020―Sep―23 Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development Sakthivel Suganya, Suresh Divya, Madasamy Parani
212 [GO] 2020―Sep―22 Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Jing Liu, Salim S. Virani, Mahboob Alam, Ali E. Denktas, Ihab Hamzeh, Umair Khalid
213 [GO] 2020―Sep―22 Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, Mauro Pistello
214 [GO] 2020―Sep―21 Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? Mohamed M. NasrAllah, Noha A. Osman, Mahmoud Elalfy, Paolo Malvezzi, Lionel Rostaing
215 [GO] 2020―Sep―19 The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li
216 [GO] 2020―Sep―18 Covid-19 and dengue: Double punches for dengue-endemic countries in Asia Harapan Harapan, Mirza Ryan, Benediktus Yohan, Rufika Shari Abidin, Firzan Nainu, Ahmed Rakib, et al. (+6)
217 [GO] 2020―Sep―18 Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes Esmaeil Farshi, Bahram Kasmapur, Anya Arad
218 [GO] 2020―Sep―16 SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Zhou, Aroona Razzaq, et al. (+10)
219 [GO] 2020―Sep―02 Interleukin-6 in Covid-19: A systematic review and meta-analysis Eric A. Coomes, Hourmazd Haghbayan
220 [GO] 2020―Sep―02 SARS-CoV -2 infection in people living with HIV : a systematic review Paola Costenaro, Chiara Minotti, Elisa Barbieri, Carlo Giaquinto, Daniele Donà
221 [GO] 2020―Aug―28 Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions Majid Teymoori-Rad, Sayed Mahdi Marashi
222 [GO] 2020―Aug―28 Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus ( MERS-CoV ) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure Mohamed M. Ba Abduallah, Maged Gomaa Hemida
223 [GO] 2020―Aug―28 SARS-CoV : Lessons learned; opportunities missed for SARS-CoV -2 Ian M. Davis
224 [GO] 2020―Aug―26 Alpha-1-antitrypsin : A possible host protective factor against Covid-19 Mariana Braccialli Loyola, Thaís Tereza Aguiar Reis, Guilherme Xavier Lyra Malcher Oliveira, Julys Fonseca Palmeira, Gustavo A. Argañaraz, Enrique R. Argañaraz
225 [GO] 2020―Aug―11 Drugs against SARS-CoV -2: What do we know about their mode of action? Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean-Claude Guillemot, et al. (+2)
226 [GO] 2020―Aug―05 Review: An insight into coronaviruses: Challenges, security and scope Niyati Shah, Vipul Davariya, Sanjeev K. Gupta, Pankaj Gajjar, Jitendra Parmar, Lancelot D'Cruz
227 [GO] 2020―Jul―31 Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV Abdellatif Bouayad
228 [GO] 2020―Jul―28 Toward better pandemic planning: An urgent priority Philip P. Mortimer
229 [GO] 2020―Jul―20 Novel coronavirus SARS-CoV -2 (Covid-19) dynamics inside the human body Asit Saha, Barsha Saha
230 [GO] 2020―Jul―20 Neuropathogenic human coronaviruses: A review Osama S. Abdelaziz, Zuraiha Waffa
231 [GO] 2020―Jul―13 Lessons from dermatology about inflammatory responses in Covid-19 Paulo Ricardo Criado, Carla Pagliari, Francisca Regina Oliveira Carneiro, Juarez Antonio Simões Quaresma
232 [GO] 2020―Jul―10 Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan
233 [GO] 2020―Jul―09 Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review Richard A. Giovane, Shadi Rezai, Ellen Cleland, Cassandra E. Henderson
234 [GO] 2020―Jul―03 Covid-19: Time for a paradigm change Franco M. Buonaguro, Paolo A. Ascierto, Gene D. Morse, Luigi Buonaguro, Igor Puzanov, Maria Lina Tornesello, et al. (+2)
235 [GO] 2020―Jul―02 Using heat to kill SARS-CoV -2 John P. Abraham, Brian D. Plourde, Lijing Cheng
236 [GO] 2020―Jun―30 Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection Heng Wee Tan, Yan-Ming Xu, Andy T. Y. Lau
237 [GO] 2020―Jun―15 YouTube as a source of patient information for Coronavirus Disease ( COVID -19): A content-quality and audience engagement analysis Tomasz Szmuda, Mohammad Talha Syed, Akshita Singh, Shan Ali, Cathrine Özdemir, Paweł Słoniewski
238 [GO] 2020―Jun―04 Emergence of novel coronavirus and progress toward treatment and vaccine Muhammad Muzamil Khan, Amna Noor, Asadullah Madni*, Mudassir Shafiq
239 [GO] 2020―Mai―20 The basic reproduction number of SARS-CoV-2 in Wuhan is about to die out, how about the rest of the World? Bootan Rahman, Evar Sadraddin, Annamaria Porreca
240 [GO] 2020―Mai―13 SARS coronavirus 2; how many more examples do we need before the world commits to decisive action? P. D. Griffiths
241 [GO] 2020―Mai―12 The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved Philip P. Mortimer
242 [GO] 2020―Apr―21 Melatonin: Roles in influenza, Covid-19, and other viral infections George Anderson, Russel J. Reiter
243 [GO] 2020―Apr―17 Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures Ying Yan, Le Chang, Lunan Wang
244 [GO] 2020―Apr―08 Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli
245 [GO] 2020―Mrz―16 Clinical features of deaths in the novel coronavirus epidemic in China Char Leung
246 [GO] 2020―Mrz―05 Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses Reina Yamaji, Magdi D. Saad, Charles T. Davis, David E. Swayne, Dayan Wang, Frank Y.K. Wong, et al. (+6)
 [1] 

246 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec